市场调查报告书
商品编码
1499560
血液透析机/腹膜透析市场:按类型、产品类型、适应症、透析场所 - 全球预测 2024-2030Hemodialysis & Peritoneal Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), Products (Hemodialysis Consumables & Supplies, Hemodialysis Equipment), Product Type, Disease Indication, Dialysis Site - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
血液透析机/腹膜透析市场规模预计2023年为843.7亿美元,2024年达897.5亿美元,预计2030年将达1317.1亿美元,复合年增长率为6.56%。
血液透析机和腹膜透析包括用于治疗肾衰竭(也称为末期肾功能衰竭(ESRD))的医疗技术、服务和相关产品。血液透析机(HD) 涉及透过透析器将患者的血液过滤到体外,以去除废物和多余的液体。另一方面,在腹膜透析(PD)中,透析液被注入腹膜腔,利用腹膜(覆盖腹部的膜)作为过滤器来吸收和排放废物。糖尿病、高血压和其他慢性疾病的增加是肾臟疾病增加的主要驱动因素,从而推动了透析需求。然而,与透析治疗和相关卫生服务相关的费用是一个主要障碍,特别是在低收入地区。此外,由于其便利性和潜在的成本效益,患者越来越喜欢家庭透析治疗。穿戴式透析设备的开拓有可能使连续透析成为一种负担较轻且可行的选择,从而彻底改变市场。此外,将数位医疗服务融入透析护理有可能透过更好的依从性和即时监测来改善患者的治疗结果。
主要市场统计 | |
---|---|
基准年[2023] | 843.7亿美元 |
预测年份 [2024] | 897.5亿美元 |
预测年份 [2030] | 1317.1亿美元 |
复合年增长率(%) | 6.56% |
区域洞察
在北美和南美,美国和加拿大由于糖尿病等文明病的高盛行率以及设备齐全的医疗设施,在血液透析机和腹膜透析市场中占据重要地位。该地区拥有强大的影响力,拥有先进的医疗基础设施、高额医疗支出以及广泛的研发活动。医疗保险和其他补助可以帮助您获得所需的透析治疗。同时,不断增长的老年人口和有利的报销政策对于欧洲、中东和非洲国家至关重要。由于政府的卫生政策,欧盟的透析治疗采用率很高,而且透析很容易取得,而且通常是免费的。此外,中国、日本和印度由于人口众多且慢性肾臟病(CKD)盛行率不断上升,因此成为亚太地区的潜在市场。快速都市化、人口老化以及糖尿病和高血压的增加(慢性肾臟病的主要原因)正在推动这些地区对透析治疗的需求。
FPNV定位矩阵
FPNV定位矩阵对于评估供应商在血液透析机和腹膜透析市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对血液透析机和腹膜透析市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在血液透析机和腹膜透析市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Hemodialysis & Peritoneal Dialysis Market size was estimated at USD 84.37 billion in 2023 and expected to reach USD 89.75 billion in 2024, at a CAGR 6.56% to reach USD 131.71 billion by 2030.
Hemodialysis and peritoneal dialysis encompass the medical technologies, services, and associated products used in the treatment of kidney failure, also called as end-stage renal disease (ESRD). Hemodialysis (HD) involves filtering a patient's blood outside the body through a dialysis machine to remove waste products and excess fluids. On the other hand, peritoneal dialysis (PD) uses the patient's peritoneum (a membrane lining the abdomen) as a filter by instilling a dialysis solution into the abdominal cavity to absorb waste products that are drained away. Increasing rates of diabetes, hypertension, and other chronic diseases are primary drivers for the rise in kidney disease, subsequently boosting the demand for dialysis. However, the expense associated with dialysis treatment and related healthcare services is a significant deterrent, particularly in lower-income regions. Moreover, there is a rising trend in patient preference for home dialysis due to its convenience and potential cost-effectiveness. The development of wearable dialysis devices could revolutionize the market by making continuous dialysis a feasible and less intrusive option. In addition, the integration of digital health services in dialysis care could improve patient outcomes through better adherence and real-time monitoring.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 84.37 billion |
Estimated Year [2024] | USD 89.75 billion |
Forecast Year [2030] | USD 131.71 billion |
CAGR (%) | 6.56% |
Regional Insights
In the Americas, the United States and Canada are significant in the hemodialysis & peritoneal dialysis market due to the high prevalence of lifestyle diseases such as diabetes and better healthcare facilities. The region is substantial due to advanced healthcare infrastructure, high spending on healthcare, and extensive research and development activities. Medicare and other subsidies support patient access to necessary dialysis treatments. At the same time, in EMEA countries, an increase in elderly populations and favorable reimbursement policies are pivotal. EU boasts of a high adoption rate of dialysis treatments facilitated by government health policies, ensuring dialysis is accessible and often free at the point of service. Moreover, China, Japan, and India represent potential Asian Pacific markets due to their large populations and increasing prevalence of chronic kidney diseases (CKD). Rapid urbanization, an aging population, and a rise in diabetes and hypertension, which are major contributors to CKD, are driving the demand for dialysis treatments in these areas.
Market Insights
The market dynamics represent an ever-changing landscape of the Hemodialysis & Peritoneal Dialysis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hemodialysis & Peritoneal Dialysis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hemodialysis & Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fresenius Medical Care Secures FDA Clearance for Advanced Hemodialysis System
Fresenius Medical Care announced its receipt of FDA 510(k) clearance for its 5008X Hemodialysis System, marking a significant advancement in dialysis treatment in the United States. This approval paves the way for Fresenius to deliver a new standard of care to American patients suffering from kidney diseases, promising improvements in treatment efficacy and patient well-being with this innovative technology. [Published On: 2024-02-08]
FDA Grants Approval for DefenCath as Antimicrobial Solution for Hemodialysis Patients
The FDA has endorsed DefenCath, developed by CorMedix Inc., a catheter lock solution combining taurolidine and heparin designed for adult patients undergoing chronic hemodialysis via a central venous catheter. This new treatment aims to provide an antimicrobial protective measure for these patients, enhancing the safety and effectiveness of their dialysis procedures. [Published On: 2023-11-15]
Launch of the Inpatient Hemodialysis Program at Rancho Los Amigos National Rehabilitation Center
Rancho Los Amigos National Rehabilitation Center introduces its Inpatient Hemodialysis Program, a significant advancement in the hospital's rehabilitation services. This new initiative highlights Rancho's dedication to medical innovation and underscores its commitment to enhancing patient care. The program is designed to provide comprehensive and continuous care to patients undergoing rehabilitation, ensuring they receive optimal treatment within the facility. This development further establishes Rancho Los Amigos as a leader in implementing forward-thinking healthcare solutions. [Published On: 2023-08-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hemodialysis & Peritoneal Dialysis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Hemodialysis & Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, DaVita Inc., Dialife SA, Evoqua Water Technologies LLC, Fresenius Medical Care AG, Hemoclean Co. Ltd., JMS Co., Ltd., Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical Inc., Rockwell Medical Inc., SB-KAWASUMI LABORATORIES, INC., STERIS Group, Toray Medical Co., Ltd., and Trivitron Healthcare.
Market Segmentation & Coverage